⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of NouStarX and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
NouStarX
↗Westport, CT, United States
NouStarX is a technology company that provides AI-powered platforms designed for the biopharmaceutical industry. Its flagship product, NousCongress, captures and structures strategic signals from major medical congresses (such as ASCO, ESMO, ASH, and EHA) to assist pharma medical, HEOR, and competitive intelligence teams in making data-driven decisions.
The company focuses on bridging the gap between clinical development and market access through AI innovation. By leveraging proprietary NLP and agentic AI frameworks, NouStarX automates evidence synthesis, protocol design, and statistical analysis planning, aiming to reduce manual research time and accelerate study start-up and regulatory readiness.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Digital Health / AI for Pharma
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Modalities:AI/ML Software
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Tulane University (Research collaboration on AI in rare disease)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Mei Yang - Co-Founder & CEO
Scientific Founders:Mei Yang
LINKS
Website:noustarx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with NouStarX. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.